Optex Systems Holdings, Inc. Announces *Amended* Three and Nine Months Ended July 3, 2022 Financial Highlights

Rhea-AI Summary

Optex Systems Holdings, Inc. (OTCQB:OPXS) reported strong financial performance for the three and nine months ended July 3, 2022. Total revenues increased by 39.2% and 19.0%, reaching $6.17 million and $15.65 million, respectively. A substantial backlog rise and operating profit improved significantly by 794.7%. The company anticipates a revenue increase of 21-23% for the year ending October 2, 2022. Despite facing inflation and supply chain issues, cash reserves grew to $5.2 million. However, net income applicable to shareholders decreased by 53% for the quarter.

Positive

• Revenue increased by 39.2% for Q3 2022 and 19.0% for the first nine months.
• Operating profit surged by 794.7% in Q3 2022, driven by increased revenue.
• Backlog rose by 9.9% to $30.0 million as of July 3, 2022, showing strong demand.
• Cash reserves increased to $5.2 million from $3.9 million, indicating a solid liquidity position.
• The company expects a revenue increase of 21-23% for the fiscal year ending October 2, 2022.

Negative

• Net income for Q3 2022 decreased by 53% compared to the prior year.
• Despite revenue growth, the applied optics center segment partially offset overall performance with a decline in the Optex Richardson segment.

RICHARDSON, TX / ACCESSWIRE / August 16, 2022 / Optex Systems Holdings, Inc. (OTCQB:OPXS), a leading manufacturer of precision optical sighting systems for domestic and worldwide military and commercial applications, announced financial highlights for the three and nine months ended July 3, 2022.

Danny Schoening, CEO of Optex Systems Holdings, Inc., commented, "We are extremely pleased with the progress over the last several months. While we continue to work issues caused by material and labor based inflation, we've been able to overcome material supply issues and maintain shipments to meet the requirements of our customers. Demand remains strong as the increase in backlog demonstrates and we continue to develop new processes and products to broaden our offerings for future growth."

Danny Schoening further commented: "Based on firm customer orders, the Company anticipates a consolidated revenue increase of 21-23% for the twelve months ending October 2, 2022 as compared to the twelve months ended October 3, 2021 combined with increased operating profit and adjusted EBITDA."

For the three and nine months ended July 3, 2022, our total revenues increased by $1.7 million and $2.5 million, or 39.2% and 19.0%, respectively, compared to the prior year period. The increase in revenue for the three and nine month periods were primarily driven by an increase in revenue at the Applied Optics Center segment, partially offset by a decrease in revenue at the Optex Richardson, over the prior year periods . During the year ended October 3, 2021, we realized a significant increase in customer orders and backlog for the Applied Optics Center segment. For the first nine months of fiscal year 2022, new orders on a consolidated basis were 86.7% higher than in the prior year period driven by increases in both operating segments.

Consolidated gross margin for the three and nine months ended July 3, 2022 increased by $0.5 million and $0.8 million, or 70.0% and 43.3%, respectively, compared to the prior year periods. The increase in margin was primarily attributable to increased revenue at the Applied Optics Center segment.

Our operating profit for the three and nine months ended July 3, 2022 increased by $0.5 million and $0.6 million, or 794.7% and 219.7%, respectively, compared to the prior year periods. The increase in operating profit was primarily driven by increases in revenue and gross margin at the Applied Optics Center segment.

As of July 3, 2022, the Company had working capital of $13.3 million, as compared to $12.9 million as of October 3, 2021. During the nine months, we generated operating cash flow of $1.9 million, and spent $236 thousand on purchases of equipment and $366 thousand for the purchase of 118,414 shares against our stock repurchase program. We ended the quarter with a strong cash balance of $5.2 million as compared to $3.9 million as of the fiscal year end 2021. As of July 3, 2022, our outstanding accounts receivable was $1.9 million. As of July 3, 2022, the Company had an outstanding payable balance of zero against our line of credit. The line of credit was renewed on April 12, 2022 through April 15, 2023 for a maximum borrowing amount of $1.1 million.

Our key performance measures for the three-and nine months ended July 3, 2022 and June 27, 2021 are summarized below.

		(Thousands)
		Three months ended												Nine months ended
Metric		July 3, 2022				June 27, 2021				% Change				July 3, 2022				June 27, 2021				% Change
Revenue		$	6,170			$	4,433				39.2			$	15,645			$	13,149				19.0
Gross Margin		$	1,268			$	746				70.0			$	2,807			$	1,959				43.3
Gross Margin %			20.6	%			16.8	%			22.6				17.9	%			14.9	%			20.1
Operating Income		$	510			$	57				794.7			$	334			$	(279	)			(219.7	)
Gain (Loss) on Change Fair Value of Warrants		$	-			$	1,167				(100.0	)		$	-			$	2,025				(100.0	)
Net Income (Loss) Applicable to Common Shareholders		$	428			$	910				(53.0	)		$	306			$	1,237				(75.3	)
Adjusted EBITDA (non-GAAP)		$	620			$	181				242.5			$	682			$	87				683.9

Beginning in April 2020 through October 3, 2021, we experienced a significant reduction in new orders and ending customer backlog in our Optex Richardson segment, resulting in an overall decrease in backlog of 40% between September 29, 2019 and October 3, 2021. We attribute the lower orders to a combination of factors including a COVID-19 driven slow-down of contract awards for both U.S. military sales and foreign military sales (FMS), combined with significant shifting in defense spending budget allocations in US military sales and FMS away from Army ground system vehicles toward other military agency applications. In addition, the pandemic has caused several program delays throughout the defense supply chain as a result of plant shutdowns, employee illnesses, travel restrictions, remote work arrangements and similar supply chain issues.

While the Applied Optics Center segment experienced a significant decline in orders during the second half of fiscal year 2020, the segment saw a sizable increase in new orders during the fiscal year ended October 3, 2021 as a result of increased military spending in Army infantry optical equipment and a larger customer base and higher customer demand for commercial optical assemblies. As of October 3, 2021, the Applied Optics Center segment backlog had increased by 153% as compared to the level on September 29, 2019. As a result of this significant shift in orders and backlog between segments, we anticipate corresponding shifts in revenue during the 2022 fiscal year, with decreasing revenue at the Optex Richardson segment, and increasing revenue at the Applied Optics Center segment.

Backlog as of July 3, 2022 has increased by $2.7 million or 9.9% to $30.0 million as compared to backlog of $27.3 million as of October 3, 2021. Backlog has increased 132.6%, or $17.1 million, from $12.9 million as of June 27, 2021.

We are seeing increases in demand and proposal activity for both our Applied Optics Center laser coated filters and optical assemblies and anticipate additional order bookings for both our commercial and military products for deliveries in fiscal year 2023 and beyond.

		(millions)
		July 3, 2022				October 3, 2021				% Change				June 27, 2021				% Change
Backlog as of period end		$	30.0			$	27.3				9.9			$	12.9				132.6

We use adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) as an additional measure for evaluating the performance of our business as "net income" includes the significant impact of noncash valuation gains and losses on warrant liabilities, noncash compensation expenses related to equity stock issues, as well as depreciation, amortization, interest expenses and federal income taxes. We believe that Adjusted EBITDA is a meaningful indicator of our operating performance because it permits period-over-period comparisons of our ongoing core operations before the excluded items, which we do not consider relevant to our operations. Adjusted EBITDA is a financial measure not required by, or presented in accordance with, U.S. generally accepted accounting principles ("GAAP").

Adjusted EBITDA has limitations and should not be considered in isolation or a substitute for performance measures calculated under GAAP. This non-GAAP measure excludes certain cash expenses that we are obligated to make. In addition, other companies in our industry may calculate Adjusted EBITDA differently than we do or may not calculate it at all, which limits the usefulness of Adjusted EBITDA as a comparative measure.

The table below summarizes our three and nine month operating results for the periods ended July 3, 2022 and June 27, 2021, in terms of both the GAAP net income measure and the non-GAAP Adjusted EBITDA measure. We believe that including both measures allows the reader better to evaluate our overall performance.

		(Thousands)
		Three months ended								Nine months ended
		July 3, 2022				June 27, 2021				July 3, 2022				June 27, 2021
Net Income (Loss) (GAAP)		$	428			$	1,374			$	306			$	1,859
Add:
Loss (Gain) on Change in Fair Value of Warrants			-				(1,167	)			-				(2,025	)
Federal Income Tax (Benefit) Expense			82				(154	)			28				(122	)
Depreciation			74				67				221				195
Stock Compensation			36				57				127				171
Interest Expense			-				4				-				9
Adjusted EBITDA - Non GAAP		$	620			$	181			$	682			$	87

Our net income decreased by ($1.0) million to $0.4 million net income for the three months ended July 3, 2022, as compared to net income of $1.4 million for the prior year period. Our adjusted EBITDA increased by $0.4 million to $0.6 million for the three months ended July 3, 2022, as compared to $0.2 million for the prior year period. The increase in adjusted EBITDA for the most recent three-month period is primarily driven by increased revenue as compared to the prior year period.

Our net income decreased by ($1.6) million to a net income of $0.3 million for the nine months ended July 3, 2022, as compared to a net income of $1.9 million for the prior year period. Our adjusted EBITDA increased by $0.6 million to $0.7 million for the nine months ended July 3, 2022, as compared to $0.1 million for the prior year period. The increase in adjusted EBITDA for the most recent nine-month period is primarily driven by increased revenue as compared to the prior year period.

During the three and nine months ended July 3, 2022, we did not recognize either a gain or a loss on the change in fair value of warrants, as the warrants had expired on August 26, 2021 in accordance with their terms. By comparison, during the three months ended June 27, 2021, we recognized a gain on the change in fair value of warrants of $1.2 million, and during the nine months ended June 27, 2021, we recognized a gain on the change in fair value of warrants of $2.0 million.

Highlights of the unaudited Condensed Consolidated and Segment Results of Operations have been prepared in accordance with GAAP. These financial highlights do not include all information and disclosures required in the consolidated financial statements and footnotes, and should be read in conjunction with our Quarterly Report on Form 10-Q for the period ended July 3, 2022 filed with the SEC on August 15, 2022 and our Annual Report on Form 10-K for the year ended October 3, 2021 filed with the SEC on December 20, 2021.

Optex Systems Holdings, Inc.
Condensed Consolidated Statements of Operations
(Unaudited)

		(Thousands, except share and per share data)
		Three months ended								Nine months ended
		July 3, 2022				June 27, 2021				July 3, 2022				June 27, 2021
Revenue		$	6,170			$	4,433			$	15,645			$	13,149
Cost of Sales			4,902				3,687				12,838				11,190
Gross Margin			1,268				746				2,807				1,959
General and Administrative Expense			758				689				2,473				2,238
Operating Income (Loss)			510				57				334				(279	)
Gain on Change in Fair Value of Warrants			-				1,167				-				2,025
Interest Expense			-				(4	)			-				(9	)
Other Income			-				1,163				-				2,016
Income Before Taxes			510				1,220				334				1,737
Income Tax (Benefit) Expense, net		$	82			$	(154	)		$	28			$	(122	)
Net Income		$	428			$	1,374			$	306			$	1,859
Deemed dividends on participating securities			-				(464	)			-				(622	)
Net income applicable to common shareholders		$	428			$	910			$	306			$	1,237
Basic income per share		$	0.05			$	0.11			$	0.04			$	0.15
Weighted Average Common Shares Outstanding - basic			8,187,318				8,101,223				8,223,492				8,204,994
Diluted income per share		$	0.05			$	0.11			$	0.04			$	0.15
Weighted Average Common Shares Outstanding - diluted		$	8,285,996			$	8,138,106			$	8,297,341			$	8,292,544

The accompanying notes in our Quarterly Report on Form 10-Q for the period ended July 3, 2022 filed with the SEC on August 15, 2022 are an integral part of these financial statements.

Optex Systems Holdings, Inc.
Condensed Consolidated Balance Sheets

		(Thousands, except share and per share data)
		July 3, 2022				October 3, 2021
		(Unaudited)
ASSETS
Cash and Cash Equivalents		$	5,169			$	3,900
Accounts Receivable, Net			1,918				3,183
Inventory, Net			8,559				7,583
Prepaid Expenses			324				262
Current Assets			15,970				14,928
Property and Equipment, Net			1,033				1,017
Other Assets
Deferred Tax Asset			948				1,288
Right-of-use Asset			3,339				3,599
Security Deposits			23				23
Other Assets			4,310				4,910
Total Assets		$	21,313			$	20,855
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts Payable		$	838			$	551
Operating Lease Liability			599				528
Accrued Expenses			787				851
Accrued Warranty Costs			196				78
Customer Deposits			256				-
Current Liabilities			2,676				2,008
Operating Lease Liability, net of current portion			2,875				3,133
Total Liabilities			5,551				5,141
Commitments and Contingencies			-				-
Stockholders' Equity
Common Stock - ($0.001 par, 2,000,000,000 authorized, 8,322,951 and 8,523,704 shares issued, and 8,322,951 and 8,488,149 outstanding, respectively)			8				9
Treasury Stock (at cost, zero and 35,555 shares held, respectively)			-				(69	)
Additional Paid in Capital			25,426				25,752
Accumulated Deficit			(9,672	)			(9,978	)
Stockholders' Equity			15,762				15,714
Total Liabilities and Stockholders' Equity		$	21,313			$	20,855

The accompanying notes in our Quarterly Report on Form 10-Q for the period ended July 3, 2022 filed with the SEC on August 15, 2022 are an integral part of these financial statements.

ABOUT OPTEX SYSTEMS

Optex, which was founded in 1987, is a Richardson, Texas based ISO 9001:2015 certified concern, which manufactures optical sighting systems and assemblies, primarily for Department of Defense (DOD) applications. Its products are installed on various types of U.S. military land vehicles, such as the Abrams and Bradley fighting vehicles, Light Armored and Armored Security Vehicles, and have been selected for installation on the Stryker family of vehicles. Optex also manufactures and delivers numerous periscope configurations, rifle and surveillance sights, and night vision optical assemblies. Optex delivers its products both directly to the military services and to prime contractors. For additional information, please visit the Company's website at www.optexsys.com .

Safe Harbor Statement

This press release contains certain forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995, including those relating to the products and services described herein. You can identify these statements by the use of the words "may," "will," "could," "should," "would," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," "likely," "forecast," "probable," and similar expressions. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. Such risks and uncertainties include, but are not limited to, continued funding of defense programs and military spending, the timing of such funding, general economic and business conditions, including unforeseen weakness in the Company's markets, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, changes in the U.S. Government's interpretation of federal procurement rules and regulations, changes in spending due to policy changes in any new federal presidential administration, market acceptance of the Company's products, shortages in components, production delays due to performance quality issues with outsourced components, inability to fully realize the expected benefits from acquisitions and restructurings or delays in realizing such benefits, challenges in integrating acquired businesses and achieving anticipated synergies, changes to export regulations, increases in tax rates, changes to generally accepted accounting principles, difficulties in retaining key employees and customers, unanticipated costs under fixed-price service and system integration engagements, changes in the market for microcap stocks regardless of growth and value and various other factors beyond our control.

You must carefully consider any such statement and should understand that many factors could cause actual results to differ from the Company's forward-looking statements. These factors include inaccurate assumptions and a broad variety of other risks and uncertainties, including some that are known and some that are not. No forward-looking statement can be guaranteed and actual future results may vary materially. The Company does not assume the obligation to update any forward-looking statement. You should carefully evaluate such statements in light of factors described in the Company's filings with the SEC, especially on Forms 10-K, 10-Q and 8-K. In various filings the Company has identified important factors that could cause actual results to differ from expected or historic results. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete list of all potential risks or uncertainties.

Contact:
IR@optexsys.com
1-972-764-5718

SOURCE: Optex Systems Holdings, Inc.

View source version on accesswire.com:
https://www.accesswire.com/712314/Optex-Systems-Holdings-Inc-Announces-Amended-Three-and-Nine-Months-Ended-July-3-2022-Financial-Highlights

FAQ

What were Optex Systems Holdings' Q3 2022 revenue figures?

Optex Systems achieved revenues of $6.17 million for the three months ended July 3, 2022, a 39.2% increase from the previous year.

How much did the backlog increase for Optex Systems as of July 3, 2022?

The backlog increased by 9.9% to $30.0 million as of July 3, 2022.

What is the projected revenue growth for Optex Systems for the year ending October 2, 2022?

Optex Systems expects a revenue increase of 21-23% for the year ending October 2, 2022.

How has net income changed for Optex Systems in Q3 2022?

Net income for Optex Systems in Q3 2022 decreased by 53% compared to the prior year.

What impact did inflation and supply chain issues have on Optex Systems?

Optex Systems faced challenges from material and labor-based inflation but managed to maintain shipments to meet customer needs.